^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    EGFRvIII mutation

    i
    Other names: EGFR, ERBB, ERBB1, Epidermal growth factor receptor
    Entrez ID:
    1956
    Related biomarkers:
    Expression
    Mutation
    CNA
    Fusion
    Others
    over2years
    Although a #osimertinib/#bevacizumab combination was marginally effective in most #glioblastoma patients with #EGFR amplification and #EGFRvIII mutation, a subgroup experienced a long-lasting meaningful benefit. @AndresFCardonaZ @ogarrieta https://t.co/UiIgugXEBN (@JNeurooncol)
    Clinical
    |
    EGFR (Epidermal growth factor receptor)
    |
    EGFR mutation • EGFR amplification • EGFRvIII mutation
    |
    Avastin (bevacizumab) • Tagrisso (osimertinib)